117 related articles for article (PubMed ID: 11753653)
41. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
42. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function.
Oh SJ; Jung JY; Shim SS; Im MY; Kim HD; Chung SY; Yoon JH
Mol Cells; 2000 Jun; 10(3):275-80. PubMed ID: 10901165
[TBL] [Abstract][Full Text] [Related]
43. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
44. Suppression of ING1 expression in sporadic breast cancer.
Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
[TBL] [Abstract][Full Text] [Related]
45. FHIT mutations in human primary gastric cancer.
Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
[TBL] [Abstract][Full Text] [Related]
46. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
[TBL] [Abstract][Full Text] [Related]
47. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
[TBL] [Abstract][Full Text] [Related]
48. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation.
Vorechovský I; Rasio D; Luo L; Monaco C; Hammarström L; Webster AD; Zaloudik J; Barbanti-Brodani G; James M; Russo G
Cancer Res; 1996 Jun; 56(12):2726-32. PubMed ID: 8665503
[TBL] [Abstract][Full Text] [Related]
49. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
50. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
[TBL] [Abstract][Full Text] [Related]
51. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
[TBL] [Abstract][Full Text] [Related]
52. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis.
Tokino T; Urano T; Furuhata T; Matsushima M; Miyatsu T; Sasaki S; Nakamura Y
Hum Genet; 1996 May; 97(5):625-31. PubMed ID: 8655143
[TBL] [Abstract][Full Text] [Related]
54. Loss of putative tumor suppressor EI24/PIG8 confers resistance to etoposide.
Mork CN; Faller DV; Spanjaard RA
FEBS Lett; 2007 Nov; 581(28):5440-4. PubMed ID: 17981155
[TBL] [Abstract][Full Text] [Related]
55. Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines.
Papp T; Niemetz A; Dosdahl N; Kumar K; Schiffmann D
Oncol Rep; 2007 Jan; 17(1):135-40. PubMed ID: 17143490
[TBL] [Abstract][Full Text] [Related]
56. Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
Moerland E; Breuning MH; Cornelisse CJ; Cleton-Jansen AM
Br J Cancer; 1997; 76(12):1550-3. PubMed ID: 9413939
[TBL] [Abstract][Full Text] [Related]
57. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients.
Severin DM; Leong T; Cassidy B; Elsaleh H; Peters L; Venter D; Southey M; McKay M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1323-31. PubMed ID: 11483345
[TBL] [Abstract][Full Text] [Related]
58. A variation in the structure of the protein-coding region of the human p53 gene.
Buchman VL; Chumakov PM; Ninkina NN; Samarina OP; Georgiev GP
Gene; 1988 Oct; 70(2):245-52. PubMed ID: 2905688
[TBL] [Abstract][Full Text] [Related]
59. Mutation analysis of the tumor suppressor gene PPP2R1B in human cervical cancer.
Yeh LS; Hsieh YY; Chang JG; Chang WW; Chang CC; Tsai FJ
Int J Gynecol Cancer; 2007; 17(4):868-71. PubMed ID: 17343570
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of p53 loss in human sarcomas.
Mulligan LM; Matlashewski GJ; Scrable HJ; Cavenee WK
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5863-7. PubMed ID: 2143022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
